Back
Supernus Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58
SUPN
Supernus Pharmaceuticals
Last Price:
$33.59
Seasonality Move:
-1.83%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing slight buying pressure.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.93 | Buy |
| 20-day SMA: | 32.28 | Buy |
| 50-day SMA: | 32.33 | Buy |
| 200-day SMA: | 34.06 | Sell |
| 8-day EMA: | 27.61 | Buy |
| 20-day EMA: | 16.74 | Buy |
| 50-day EMA: | 8.1 | Buy |
| 200-day EMA: | 2.24 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.12 | Buy |
| Relative Strength Index (14 RSI): | 60.79 | Buy |
| Chaikin Money Flow: | 84242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.59 - 33.15) | Buy |
| Bollinger Bands (100): | (31.42 - 32.94) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 33.52 while SUPN 8-day simple moving average is 32.93, which is a Buy signal.
-
The stock price of SUPN is 33.52 while Supernus Pharmaceuticals 20-day SMA is 32.28, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day simple moving average is 32.33 while SUPN share price is 33.52, making it a Buy technically.
-
SUPN stock price is 33.52 and Supernus Pharmaceuticals 200-day simple moving average is 34.06, creating a Sell signal.
SUPN Technical Analysis vs Fundamental Analysis
Buy
58
Supernus Pharmaceuticals (SUPN)
is a Buy
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a BuyThe current Supernus Pharmaceuticals [SUPN] share price is $33.52. The Score for SUPN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.9B
Price in USD:
33.52
Share Volume:
1.2M
Supernus Pharmaceuticals 52-Week Range
52-Week High:
40.28
52-Week Low:
27.05
Buy
58
Supernus Pharmaceuticals (SUPN)
is a Buy
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?The Supernus Pharmaceuticals stock price is 33.52 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is not overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
-
Supernus Pharmaceuticals share price is 33.52 while SUPN 8-day exponential moving average is 27.61, which is a Buy signal.
-
The stock price of SUPN is 33.52 while Supernus Pharmaceuticals 20-day EMA is 16.74, which makes it a Buy.
-
Supernus Pharmaceuticals 50-day exponential moving average is 8.10 while SUPN share price is 33.52, making it a Buy technically.
-
SUPN stock price is 33.52 and Supernus Pharmaceuticals 200-day simple moving average is 2.24, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.88 per share, and an increase next year of $0.55 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is 9.12, suggesting Supernus Pharmaceuticals is a Buy
-
Supernus Pharmaceuticals Relative Strength Index (RSI) is 60.79, which suggest Supernus Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Supernus Pharmaceuticals is (31.59 - 33.15), which suggest Supernus Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Supernus Pharmaceuticals is (31.42 - 32.94), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.